Pharmaceutical Industry

Healthy Investment

• The value of sector annual production is Eur 308 mill.
• Generic drugs development strategy
• Cost efficiency & intellectual capacities
• Market potentials & commitment to quality

Serbia Business produced several briefs on market status covering producers, distributors and local outsourced partners. Pharma sector in Serbia is one of the most perspective business areas.